CureVac's COVID-19 vaccine triggers immune response in Phase I trial ...Middle East

CureVac's experimental COVID-19 vaccine triggered an immune response in humans, it said on Monday, putting the German biotech company on track to start mass testing this year as the race to end the pandemic heats up. The biotech firm is using the so-called messenger RNA (mRNA) approach, the same as Moderna as well as BioNTech and its partner Pfizer, although they started mass testing on humans in late July.

Hence then, the article about curevac 39 s covid 19 vaccine triggers immune response in phase i trial was published today ( Monday 02/11/2020 - 03:22 PM ) and is available on Yahoo ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CureVac's COVID-19 vaccine triggers immune response in Phase I trial )

Also on site :

• CNN Tests the Waters With a Creator-Driven Concept
• SAG-AFTRA Launches Verticals Agreement for Microdramas
• 98% of homes that used government insulation scheme need mould repairs